PCR-based development of DNA substrates containing modified bases: An efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 24, 1996, Pages 13623-13628

  Bailly, Christian ^a,b   Payet, Dominique ^c   Travers, Andrew A ^c   Waring, Michael J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

DNA recognition; Drug DNA interaction; Footprinting; Protein DNA binding; Purine 2 amino group

Indexed keywords

2,6 DIAMINOPURINE; DEOXYURIDINE; GUANOSINE; INOSINE;

BINDING SITE; CHEMICAL STRUCTURE; CONFERENCE PAPER; DNA FOOTPRINTING; DROSOPHILA MELANOGASTER; LIGAND BINDING; MOLECULAR RECOGNITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE;

2-AMINOPURINE; BASE COMPOSITION; BASE SEQUENCE; BINDING SITES; DEOXYRIBONUCLEASE I; DISTAMYCINS; DNA; DNA FOOTPRINTING; DNA PRIMERS; GUANOSINE; HIGH MOBILITY GROUP PROTEINS; HYDROGEN BONDING; INOSINE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PLASMIDS; PLICAMYCIN; POLYMERASE CHAIN REACTION;

DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0030450388     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.24.13623     Document Type: Article

References (40)

1. Seeman, N. C., Rosenberg, J. M. & Rich, A. (1976) Proc. Natl. Acad. Sci. USA 73, 804-808.
2. Zhurkin, V. B. (1983) FEBS Lett. 158, 293-297.
3. Zhurkin, V. B. (1985) J. Biomol. Struct. Dyn. 2, 785-804..
4. Drew, H. R. & Travers, A. A. (1985) J. Mol. Biol. 186, 773-790.
5. Flaus, A., Luger, K., Tan, S. & Richmond, T. J. (1996) Proc. Natl. Acad. Sci. USA 93, 1370-1375.
6. Sauer, R. T. (1995) Nature Struct. Biol. 2, 7-9.
7. Travers, A. A. (1995) Nature Struct. Biol. 2, 615-618.
8. Tomasz, M. (1994) in Molecular Aspects of Anticancer Drug-DNA Interactions, eds. Neidle, S. & Waring, M. J. (Macmillan, London), Vol. 2, pp. 312-349.
9. Thurston, D. E. (1993) in Molecular Aspects of Anticancer Drug-DNA Interactions, eds. Neidle, S. & Waring, M. J. (Macmillan, London), Vol. 1, pp. 54-88.
10. Kopka, M. L., Goodsell, D., Baikalov, I., Grzeskowiak, K., Cascio, D. & Dickerson, R. E. (1994) Biochemistry 33, 13593-13610.
11. Werner, M. H., Ruth, J. R., Gronenborn, A. M. & Clore, G. M. (1995) Cell 81, 705-714.
12. Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R. & Wright, P. E. (1995) Nature (London) 376, 791-795.
13. Bailly, C. & Waring, M. J. (1995) J. Am. Chem. Soc. 117, 7311-7316.
14. Bailly, C. & Waring, M. J. (1995) Nucleic Acids Res. 23, 885-892.
15. Wagner, C. R., Hamana, K. & Elgin, S. C. R. (1992) Mol. Cell. Biol. 12, 1915-1923.
16. Ner, S. S., Churchill, M. E. A., Searles, M. A. & Travers, A. A. (1993) Nucleic Acids Res. 21, 4369-4371.
17. Churchill, M. E. A., Jones, D. N. M., Glaser, T., Hefner, H., Searles, M. A. & Travers, A. A. (1995) EMBO J. 14, 1264-1275.
18. Wolfe, S. A., Ferentz, A. E., Grantcharova, V., Churchill, M. E. A., Verdine, G. L. (1995) Chem. Biol. 2, 213-221.
19. Drew, H. R. & Travers, A. A. (1984) Cell 37, 491-502.
20. Drew, H. R., Weeks, J. R. & Travers, A. A. (1985) EMBO J. 4, 1025-1032.
21. Low, C. M. L., Drew, H. R. & Waring, M. J. (1984) Nucleic Acids Res. 12, 4865-4879.
22. Smith, J. M. & Thomas, D. J. (1990) Comput. Appl. Biosci. 6, 93-99.
23. Dabrowiak, J. C. & Goodisman, J. (1989) in Chemistry and Physics of DNA-Ligand Interactions, ed. Kallenbach, N. R. (Adenine, Schenectady, NY), pp. 143-174.
24. Sayers, E. W & Waring, M. J. (1993) Biochemistry 32, 9094-9107.
25. Bailly, C., Hamy, F. & Waring, M. J. (1996) Biochemistry 35, 1150-1161.
26. Van Dyke, M. W. & Dervan, P. B. (1983) Biochemistry 22, 2373-2377.
27. Van Dyke, M. W., Hertzberg, R. P. & Dervan, P. B. (1983) Proc. Natl. Acad. Sci. USA 79, 5470-5474.
28. Portugal, J. & Waring, M. J. (1987) Eur. J. Biochem. 167, 281-289.
29. Stankus, A., Goodisman, J. & Dabrowiak, J. C. (1992) Biochemistry 31, 9310-9318.
30. Klevit, R. E., Wemmer, D. E. & Reid, B. R. (1986) Biochemistry 25, 3296-3303.
31. Coll, M., Frederick, C. A., Wang, A. H. J. & Rich, A. (1987) Proc. Natl. Acad. Sci. USA 84, 8385-8389.
32. Pelton, J. G. & Wemmer, D. E. (1990) J. Am. Chem. Soc. 112, 1393-1399.
33. Kopka, M. L. & Larsen, T. A. (1992) in Nucleic Acid Targeted Drug Design, eds. Propst, C. L. & Perun, T. J. (Dekker, New York), pp. 303-374.
34. Goodsell, D., Kopka, M. L. & Dickerson, R. E. (1995) Biochemistry 34, 4983-4993.
35. Keniry, M. A., Banville, D. L., Simmonds, P. M. & Shafer, R. (1993) J. Mol. Biol. 231, 753-767.
36. Sastry, M. & Patel, D. J. (1993) Biochemistry 32, 6588-6604.
37. Kopka, M. L., Yoon, C., Goodsell, D., Pjura, P. & Dickerson, R. E. (1985) Proc. Natl. Acad. Sci. USA 82, 1376-1380.
38. Chow, C. S., Whitehead, J. P. & Lippard, S. J. (1994) Biochemistry 33, 15124-15130.
39. Bailly, C., Waring, M. J. & Travers, A. A. (1995) J. Mol. Biol. 253, 1-7.
40. Nelson, H. C. M., Finch, J. T., Luisi, B. F. & Klug, A. (1987) Nature (London) 330, 221-226.